Next Article in Journal
Parathyroid Hormone Related Protein (PTHrP)-Associated Molecular Signatures in Tissue Differentiation and Non-Tumoral Diseases
Next Article in Special Issue
Cellular Stress: Modulator of Regulated Cell Death
Previous Article in Journal
Effect of Ripening and In Vitro Digestion on Bioactive Peptides Profile in Ras Cheese and Their Biological Activities
Previous Article in Special Issue
The ACSL4 Network Regulates Cell Death and Autophagy in Diseases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism

Talent Recruitment and Career Support (TRACS) Office, Nanyang Technological University, N2.1 B4-01, 76 Nanyang Drive, Singapore 637331, Singapore
Biology 2023, 12(7), 949; https://doi.org/10.3390/biology12070949
Submission received: 21 April 2023 / Revised: 23 June 2023 / Accepted: 30 June 2023 / Published: 3 July 2023
The main purpose of this Special Issue is to provide readers with current understandings of the interactions and causal relations among injury stimuli (including microorganism infections), immune response and overnutrition/lipotoxicity in disease pathogenesis. Special emphasis is placed on microbiota infection, cell self-destruction in response to inflammation, metabolic homeostasis and transient overnutrition in disease initiation, progression and resolution through the dissipation of nutrients for cell metabolism and tissue regeneration.
During the COVID-19 pandemic, which was experienced by the whole world in the past three years, the biggest mystery was the heterogenous and individualized response of the human immune system [1]. Why were most of COVID-19 cases asymptomatic or mild, while some cases were severe or fatal, featured by a cytokine storm? A better understanding of COVID-19 as a disease requires distinguishing between an infection and a disease [2]. Infection is the presence of microorganisms [2], while disease is the symptoms and pathological conditions. Furthermore, disease severity is affected by many factors including pathogen virulence, pathogen load and the inflammatory response by the immune system [2]. In asymptomatic or mild COVID-19 cases, the SARS-CoV-2 viral infection is self-limiting [3,4], and the damaged cells can be effectively cleared by localized programmed cell death via processes like apoptosis, pyroptosis [5] and necroptosis [6]. Yet, in severe cases of COVID-19, of which individuals with metabolic syndromes such as hypertension, type 2 diabetes mellitus, cardiovascular disease, morbid obesity and chronic pulmonary disease were at particularly high risk [3,4], the immunopathological change is distinct [3,4], making severe COVID-19 more of an autoimmune disease [7] than a simple viral infection. Due to the pre-existing overnutrition state in the body, which is worsened by the conversion of nutrients from deceased cells within macrophages, lipotoxicity surpasses SARS-CoV-2 viral infection and becomes the dominant injurious stimulus for cell damage [8,9], which leads to systemic inflammation and multiorgan failure in severe cases [3,4].
Immunologists have long been puzzled by the self-destructive nature of the inflammatory response [10]. In our recent article, we proposed the “self-destroy and rebuild” strategy of inflammatory response [11]. Inflammation can be elicited by various harmful stimuli, such as microbial/viral infections, allergic reactions, chemical insults, lipotoxicity and tissue damage [12]. The process of breaking down damaged cells and converting them into various macronutrients for tissue regeneration and cell metabolism is one of the most important functions of the immune system in maintaining health. A localized self-destructive inflammatory response is protective if the immune system can effectively eliminate the harmful stimuli and initiate the healing process. Cell self-destruction (programmed cell death) includes apoptosis, pyroptosis, necroptosis and necrosis [13]. Phagocytosis is employed to remove various cell debris produced by cell self-destruction and converts these debris into macronutrients. The immune system thus becomes a powerful nutrient regenerator. At this time, nutrient metabolism and immunity are interrelated and integrated and play essential roles in disease prevention and immunonutrition acquisition [14]. In the event of microbial/viral infections, the nutritional flux produced by infected host cell self-destruction (inflammation) together with those produced by daily homeostatic apoptosis [15] may create transient overnutrition [16]. Such transient overnutrition can be dissipated through cell or tissue regeneration. From the above, we can find that as a defense measure, a self-destructive inflammatory response is essential for health and daily homeostasis.
Inflammation becomes problematic only when the injurious stimulus cannot be resolved by a self-destructive inflammatory response and is instead escalated. One such case is lipotoxicity as the injurious stimulus as well as the inflammatory response product. It is well documented that excessive serum amino acids from high protein feeding results in increased hepatic de novo lipogenesis [17,18]. As cell self-destruction and cell debris degradation can also generate amino acids that circulate throughout the circulatory system, when the nutrition generated by the degradation of infection-damaged cells exceeds the nutritional requirements for tissue regeneration, most of the excess nutrients will be converted into lipid intermediates [16]. Lipid intermediates will invade healthy non-adipose tissue, leading to lipotoxicity [8,9] and further tissue damage. Damaged cells are forced to undergo programmed cell death and to produce more nutrients. In such a case, the main product (lipid intermediates) of the inflammatory response is also a strong harmful stimulus for tissue/cell damage and is amplified during the inflammatory response, forming a vicious cycle, making inflammatory response extremely destructive [16].
Owing to the self-destructive inflammatory response and the swift and efficient removal of dead cell debris by efferocytosis [15], most microorganism infections are self-limiting, and inflammation is often asymptomatic, even though these microorganisms also cause harm to human somatic cells. Although for convenience, these “non-invasive” microorganisms are defined as commensal microbes and disease-causing microorganisms are defined as pathogens, no sharp and clear distinction exists between pathogens and symbiotic microbes. On one hand, microbial cells are closely related to human health [19]. Without the support of full-spectrum essential nutrients from diverse microbiota, malnutrition and nutritional imbalances occur, leading to metabolic syndrome, including morbid obesity, diabetes, liver disease, allergies and a compromised immune system [20]. On the other hand, many of these microorganisms in the normal microbiota are opportunistic pathogens [21]. In a state of overnutrition, the efferocytosis process may be delayed, leaving the uncleared self-destructed somatic cell debris as the nutrition base for microorganism proliferation. Overgrowth of any microbial species in the human body (like in the respiratory or gastrointestinal tract) coupled with the lipotoxicity from overnutrition can exacerbate inflammation at these sites and lead to disease [22]. It is the effective programmed cell death pathways running under a balanced nutrition state in the body that shapes a potentially pathogenic microbiome into a commensal microbiome.
Programmed cell death can also happen in a non-inflammatory apoptotic way. Apoptosis occurs in various tissues of all multicellular organisms during development and homeostatic renewal of cells [15]. Dead cells and cell debris must be removed before being replaced to maintain normal functioning of an organ and to avoid extensive inflammatory responses [15]. Problematic clearance of apoptotic cell debris will cause all kinds of diseases [15]. For example, apoptosis resistance in Epstein–Barr virus (EBV)-positive cells is closely associated with nasopharyngeal carcinoma (NPC) [23].
In summary, this Special Issue invites new research articles and reviews on topics related to (but not limited to) microbial/viral-infection-induced host cell self-destruction and immunonutrition acquisition, programmed cell death, metabolites, cell self-destruction in illness, transient overnutrition, lipotoxicity, involuntary weight loss and autoimmunity.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yong, E. Immunology Is Where intuition Goes to Die. The Atlantic. 5 August 2020. Available online: https://www.theatlantic.com/health/archive/2020/08/covid-19-immunity-is-the-pandemics-central-mystery/614956/ (accessed on 21 April 2023).
  2. Humphries, D.L.; Scott, M.E.; Vermund, S.H. Pathways Linking Nutritional Status and Infectious Disease: Causal and Conceptual Frameworks. In Nutrition and Infectious Diseases. Nutrition and Health; Humphries, D.L., Scott, M.E., Vermund, S.H., Eds.; Humana: Cham, Switzerland, 2021. [Google Scholar] [CrossRef]
  3. Azkur, A.K.; Akdis, M.; Azkur, D.; Sokolowska, M.; van de Veen, W.; Brüggen, M.C.; O’Mahony, L.; Gao, Y.; Nadeau, K.; Akdis, C.A. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020, 75, 1564–1581. [Google Scholar] [CrossRef]
  4. van Eijk, L.E.; Binkhorst, M.; Bourgonje, A.R.; Offringa, A.K.; Mulder, D.J.; Bos, E.M.; Kolundzic, N.; Abdulle, A.E.; van der Voort, P.H.; Olde Rikkert, M.G.; et al. COVID-19: Immunopathology, pathophysiological mechanisms, and treatment options. J. Pathol. 2021, 254, 307–331. [Google Scholar] [CrossRef] [PubMed]
  5. Wang, M.; Chang, W.; Zhang, L.; Zhang, Y. Pyroptotic cell death in SARS-CoV-2 infection: Revealing its roles during the immunopathogenesis of COVID-19. Int. J. Biol. Sci. 2022, 18, 5827–5848. [Google Scholar] [CrossRef]
  6. Sun, C.; Han, Y.; Zhang, R.; Liu, S.; Wang, J.; Zhang, Y.; Chen, X.; Jiang, C.; Wang, J.; Fan, X.; et al. Regulated necrosis in COVID-19: A double-edged sword. Front. Immunol. 2022, 13, 917141. [Google Scholar] [CrossRef]
  7. Icenogle, T. COVID-19: Infection or Autoimmunity. Front. Immunol. 2020, 11, 2055. [Google Scholar] [CrossRef] [PubMed]
  8. Hegyi, P.; Szakács, Z.; Sahin-Tóth, M. Lipotoxicity and Cytokine Storm in Severe Acute Pancreatitis and COVID-19. Gastroenterology 2020, 159, 824–827. [Google Scholar] [CrossRef]
  9. Schaffer, J.E. Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death: Introduction to a Thematic Review Series. J. Lipid Res. 2016, 57, 1327–1328. [Google Scholar] [CrossRef] [Green Version]
  10. Shi, F.D.; Ljunggren, H.G.; Sarvetnick, N. Innate immunity and autoimmunity: From self-protection to self-destruction. Trends Immunol. 2001, 22, 97–101. [Google Scholar] [CrossRef]
  11. Yu, L.; Abd Ghani, M.K.; Aghemo, A.; Barh, D.; Bassetti, M.; Catena, F.; Gallo, G.; Gholamrezanezhad, A.; Kamal, M.A.; Lal, A.; et al. SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19. Curr. Med. Chem. 2023, 92, 725. [Google Scholar] [CrossRef] [PubMed]
  12. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2017, 9, 7204–7218. [Google Scholar] [CrossRef] [Green Version]
  13. Jorgensen, I.; Rayamajhi, M.; Miao, E.A. Programmed cell death as a defence against infection. Nat. Rev. Immunol. 2017, 17, 151–164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Broderick, N.A. A common origin for immunity and digestion. Front. Immunol. 2015, 6, 72. [Google Scholar] [CrossRef] [PubMed]
  15. Nagata, S. Apoptosis and Clearance of Apoptotic Cells. Annu. Rev. Immunol. 2018, 36, 489–517. [Google Scholar] [CrossRef] [PubMed]
  16. Yu, B.X.; Yu, L.G.; Klionsky, D.J. Nutrition Acquisition by Human Immunity, Transient Overnutrition and the Cytokine Storm in Severe Cases of COVID-19. Med. Hypotheses 2021, 155, 110668. [Google Scholar] [CrossRef]
  17. Charidemou, E.; Ashmore, T.; Li, X.; McNally, B.D.; West, J.A.; Liggi, S.; Harvey, M.; Orford, E.; Griffin, J.L. A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans. JCI Insight 2019, 4, e124819. [Google Scholar] [CrossRef] [Green Version]
  18. Luukkonen, P.K.; Qadri, S.; Ahlholm, N.; Porthan, K.; Männistö, V.; Sammalkorpi, H.; Penttilä, A.K.; Hakkarainen, A.; Lehtimäki, T.E.; Gaggini, M.; et al. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 2022, 76, 526–535. [Google Scholar] [CrossRef]
  19. Backhed, F.; Ley, R.E.; Sonnenburg, J.L.; Peterson, D.A.; Gordon, J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307, 1915–1920. [Google Scholar] [CrossRef] [Green Version]
  20. Kumar, R.; Sood, U.; Gupta, V.; Singh, M.; Scaria, J.; Lal, R. Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis. Indian J. Microbiol. 2020, 60, 12–25. [Google Scholar] [CrossRef]
  21. Rath, S.; Rud, T.; Karch, A.; Pieper, D.H.; Vital, M. Pathogenic functions of host microbiota. Microbiome 2018, 6, 174. [Google Scholar] [CrossRef] [Green Version]
  22. Dickson, R.P.; Martinez, F.J.; Huffnagle, G.B. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 2014, 384, 691–702. [Google Scholar] [CrossRef] [Green Version]
  23. Komano, J.; Sugiura, M.; Takada, K. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt’s lymphoma cell line Akata. J. Virol. 1998, 72, 9150–9156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yu, L. Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism. Biology 2023, 12, 949. https://doi.org/10.3390/biology12070949

AMA Style

Yu L. Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism. Biology. 2023; 12(7):949. https://doi.org/10.3390/biology12070949

Chicago/Turabian Style

Yu, Ligen. 2023. "Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism" Biology 12, no. 7: 949. https://doi.org/10.3390/biology12070949

APA Style

Yu, L. (2023). Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism. Biology, 12(7), 949. https://doi.org/10.3390/biology12070949

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop